Director, US Health Economic Value Access – HEVA

Role Overview

• Partner with Policy and Payer Marketing on engagement strategy with external partners and formulary decision-makers primarily in national/regional health plans, CMS, integrated delivery networks (IDNs), ATCs, Large physician groups (LPGs).
• Build and drive the US value proposition story for AMTAGVI and pipeline therapies to include but not limited to impact of complete and partial responses on PROs, productivity and future treatment costs and pharmacoeconomic impact of evolving treatment patterns.
• Incorporate health economics, business analytics and competitive intelligence into the development of innovative strategies to gain, improve and defend public and private market access, specifically, pricing (and contracting) strategic planning within Market Access to create innovative proposals to meet public and private payer needs.
• Lead development and maintenance of formulary submission packages, total cost of care US models and other economic modeling and healthcare resource use analyses.
• Support field-based cross-functional teams to provide pharmacoeconomic expertise in access engagements.
• Compliantly manage operations of Iovance Pricing Committee, GTN implications review and update charter and plan agendas to drive development of Committee recommendations.
• Assess clinical and economic data gaps at key accounts and collaborate with internal stakeholders: Medical, Policy, Reimbursement HEOR, Payer Accounts, Marketing, Legal to provide insight into health economic value needs.
• Support Market Access Account team(s) with Payer and Formulary Decision Makers at key congresses, such as PCMA, AMCP, ASTCT as needed.
• Work cross functionally as a liaison with the brand teams to develop, implement, and communicate strategies and tactics to ensure alignment within the Market Access team on key cross-functional priorities.
• Partnering with Commercial Strategy on Market Readiness, trial design and endpoint considerations, FDAMA and value evidence creation and Go-to-Market approach.
• Assist on pipeline products and indications to generate key evidence and value proposition.
• Provide strategic support and clinical-economic content expertise in innovation and partnership opportunities.
• Operate at the highest level of compliance and professional standards demonstrated by embracing ethical decision-making practices and guidelines in all aspects of our organization.
• Serve as internal point of contact for all health care economic policy.

Requirements

• Advanced Degree in Health Economics, Public Health, Economics, or related field.
• 12 plus years of experience in Healthcare or Pharmaceutical Industry with a focus on health economics and market access.
• Strong background/experience in pharmacoeconomic, cost-effectiveness, HEOR and payer interactions.
• Strong analytical and qualitative skills, expected to have experience in developing economic models, conducting cost effectiveness analysis, analyzing real-world data.
• Proven ability to develop and maintain relationships with key decision-makers in the US healthcare/economics ecosystem.
• Experience in assessing and analyzing clinical and HEOR data gaps to provide relevant access solutions.
• Must be a strong team player and effectively interface with other internal departments including regional business units, marketing, sales, medical affairs, and clinical operations.
• Excellent communication and presentation skills. Ability to communicate complex concepts to both internal and external stakeholders is crucial.
• Strategic thinking and decision-making abilities – able to anticipate future market trends and make data driven recommendations to business growth.
• Ability to take initiative and work both independently and in a team environment multi-tasking, time management, and organizational skills with proficiency in Microsoft applications.
• Doctorate degree (PharmD, MD, DO or PhD) preferred.
• Cell therapy, Hematology/Oncology experience preferred.

Tech Stack

• Go

Benefits

• Travel required, including overnights and some weekends (up to 20%)